An endangered tribe has developed a severe skeletal deformity. A university research has identified a mineral supplement as a possible remedy, though clinical trials are yet to be conducted. Should the District Magistrate (DM) use this research on the tribe? Discuss from the perspective of medical and administrative ethics.
Subtopic: Ethics · medical and administrative ethics, untested interventions on a vulnerable group
Show model answer outline
- The DM should not proceed: administering an untested supplement under administrative authority is an unacknowledged experiment without any of an experiment's safeguards.
- Real consent is near-impossible where a dependent, unwell community faces a request carrying the authority of the state.
- Vulnerability triggers additional safeguards in research ethics, not fewer — the 'nothing to lose' instinct inverts the principle.
- Mineral supplementation is not risk-free; excess selenium, fluoride or iron causes serious toxicity, especially in undernourished populations.
- Justice is breached when a group bears experimental risk because it is poor, remote and administratively reachable.
- The correct route is an institutional ethics committee, ICMR guidelines and a registered trial — not district discretion.
- Administrative power should be used to bring specialists, diagnosis, water and nutrition, which need no experiment.